Clinical recommendations on lung cancer management during the COVID ‐19 pandemicClinical Guideline Published on 2020-05-292022-10-28 Journal: Thoracic cancer [Category] COVID-19, MERS, SARS, [키워드] affected anticancer clinical Clinical management Coronavirus disease 2019 COVID COVID‐19 COVID‐19 differential diagnosis effective Fever healthy individual Immunosuppression Infection international public health lung cancer lung cancer patient lung neoplasms malignancy management outcome pandemic Patient Patient management Patients with cancer poor prognosis Prevent provide recommendation respiratory symptoms Significant susceptible therapy Treatment undergo [DOI] 10.1111/1759-7714.13498 PMC 바로가기 [Article Type] Clinical Guideline
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statementResearch article Published on 2020-05-012022-10-05 Journal: Radiotherapy and oncology : journal of the Europea [Category] SARS, 유전자 메커니즘, [키워드] benefit cancer patient caused characterized Consensus contributed COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 positive patient cranial DelPhi effort Factor healthcare include increased risk International joint lung cancer lung cancer patient Non-small cell lung cancer pandemic Patient patient triage performance status postoperative Practice Pragmatic Prognosis Prophylactic provided Radiation Radiotherapy recommendation reduced resource resources Result risk Severe COVID-19 Infection Small cell lung cancer susceptibility Thoracic Treatment treatment strategy were assessed [DOI] 10.1016/j.radonc.2020.04.001 [Article Type] Research article
Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infectionLetter to the Editor Published on 2020-04-282022-10-30 Journal: Molecular Cancer [Category] COVID-19, Fulltext, SARS, [키워드] ACE2 age Cancer cancer patient Cell COVID-19 COVID-19 patient enzyme event Gene Expression higher risk investigated lung lung adenocarcinoma lung cancer lung cancer patient Patient patients Prognosis protein levels recent reported SARS-CoV-2 SARS-COV-2 infection susceptibility susceptible tissue expression TMPRSS2 transmembrane serine protease [DOI] 10.1186/s12943-020-01209-2 PMC 바로가기 [Article Type] Letter to the Editor
Results of Multilevel Containment Measures to Better Protect Lung Cancer Patients From COVID-19: The IEO ModelOncology Published on 2020-04-222022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] acute respiratory syndrome administration Admission anticancer applied benefit Better Cancer Care China clinical conditions Comorbidities concerning Containment containment measures Contamination coronavirus coronavirus disease country Course COVID-19 COVID-19 outbreak COVID-19 pandemic COVID-19 severity disease Elderly patient European expected Follow-up visit high risk histology hospital hospitals Infection International Interstitial lung disease Italy lung cancer lung cancer patient management measure media Model Mortality myelosuppression National Novel coronavirus oncologist oncology organization pandemic Patient Potential PROTECT pulmonary complication receiving recommendation reported required Result risk SARS-CoV-2 SARS-CoV2 infection significantly Spread suspected patient Symptom the disease Toxicity Treatment WHO with COVID-19 World Health Organization [DOI] 10.3389/fonc.2020.00665 PMC 바로가기 [Article Type] Oncology